Biohaven (BHVN) Misses on Q3 Earnings, Inks $1.24B Pfizer Deal

Published on November 10, 2021

Biohaven's (BHVN) sole approved drug, Nurtec ODT, for treating migraine, continues to demonstrate strong demand in the United States. The company signs an agreement with Pfizer, granting the latter ex-U.S....